Centro Cardiologico Monzino

Running trials

• Not yet recruiting

  Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR

  NCT07696182· Abbott Medical Devices· Source

• Recruiting

  Computational μFR-Guided Versus Angiographic Guidance in Drug-Coated Balloon Angioplasty

  NCT07917234· Centro Cardiologico Monzino· Source

• Active, not recruiting

  EXIT-CVD Project: Evidence Based Exit Strategies for the Cardiovascular Disease Continuum Trough Early Detection, Treatment and Evaluation

  NCT07857031· Centro Cardiologico Monzino· Source

• Recruiting

  A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07771465· Phase 3· Kardigan, Inc.· Source

• Recruiting

  OPTION-EMEA Clinical Trial

  NCT07349121· Boston Scientific Corporation· Source

• Active, not recruiting

  Radiomics Analysis of CMR Imaging for Arrhythmic Risk Prediction in Hypertrophic Cardiomyopathy, With Longitudinal Risk Reassessment After Mavacamten Therapy in Obstructive Patients

  NCT07695272· Centro Cardiologico Monzino· Source

• Recruiting

  Natural History of Atrial Fibrillation-Induced Tricuspid Valve Remodeling in the Absence of Significant Tricuspid Regurgitation: A Three-Dimensional Echocardiographic Study

  NCT07617974· Centro Cardiologico Monzino· Source

• Recruiting

  Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?

  NCT07295522· Phase 4· IRCCS Policlinico S. Donato· Source

• Recruiting

  Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration

  NCT07523620· Abbott Medical Devices· Source

• Recruiting

  Derivation and Validation of the Aortic Valve Echocardiographic Calcium Score to Confirm Severe Aortic Stenosis: the Echo-AVCS Study

  NCT07620925· Azienda Ospedaliera "Sant'Andrea"· Source

• Recruiting

  A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

  NCT07210723· Phase 2/3· Kardigan, Inc.· Source

• Active, not recruiting

  WATCHMAN FLX Pro European Registry

  NCT07262255· Boston Scientific Corporation· Source

• Active, not recruiting

  BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF

  NCT07181590· Abbott Medical Devices· Source

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Insights From the FAST-TRACK CABG Trial: a Clinical Outcome Study in Patient With Previous Surgical Revascularization for Complex Three-vessel or Left Main Coronary Artery Disease Based on Coronary Computed Tomography Angiogram, and Fractional Flow Reserve Derived by Computed Tomography

  NCT07628270· Centro Cardiologico Monzino· Source

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Amgen· Source

• Recruiting

  Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients

  NCT06861361· Ceric Sàrl· Source

• Active, not recruiting

  Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

  NCT06858878· Phase 3· Amgen· Source

• Active, not recruiting

  Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

  NCT06858839· Phase 3· Amgen· Source

• Active, not recruiting

  Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

  NCT07091682· Biotronik AG· Source

• Active, not recruiting

  REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure

  NCT06557798· The Leeds Teaching Hospitals NHS Trust· Source

• Recruiting

  Prospective Multicenter Registry of Gender, Diversity and Inclusion (GEDI) of Women With Acute Coronary Syndrome

  NCT06441942· IRCCS San Raffaele· Source

• Recruiting

  Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes

  NCT07291609· Azienda Ospedaliera "Sant'Andrea"· Source

• Recruiting

  SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective

  NCT06373601· Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS· Source

• Recruiting

  MECKI-Amyloidosis: Assessment of the Exercise Capacity and Prognosis of Patients with Cardiac Amyloidosis

  NCT06799273· Centro Cardiologico Monzino· Source

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

• Recruiting

  DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System

  NCT06074549· Elixir Medical Corporation· Source

• Active, not recruiting

  Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation

  NCT06096337· Boston Scientific Corporation· Source

• Recruiting

  CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine

  NCT06158698· Phase 3· Niguarda Hospital· Source

• Active, not recruiting

  Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

  NCT06008756· Phase 3· Merck Sharp & Dohme LLC· Source

• Recruiting

  Post-Market Clinical Follow Up Study With Navitor Valve

  NCT06008080· Abbott Medical Devices· Source

• Recruiting

  Trustworthy, Integrated Artificial Intelligence Tools for Predicting High-risk CORonary PlaqueS

  NCT06410690· Centro Cardiologico Monzino· Source

• Recruiting

  Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

  NCT06311708· Tenaya Therapeutics· Source

• Recruiting

  Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

  NCT05491200· Phase 4· Research Maatschap Cardiologen Rotterdam Zuid· Source

• Active, not recruiting

  Italian Digital Primary Cardiovascular Prevention Study

  NCT05339841· Centro Cardiologico Monzino· Source

• Recruiting

  Italian Anderson Fabry Disease Cardiovascular Registry

  NCT06806813· IRCCS Azienda Ospedaliero-Universitaria di Bologna· Source

• Recruiting

  MYTHS - MYocarditis THerapy With Steroids

  NCT05150704· Phase 3· Niguarda Hospital· Source

• Active, not recruiting

  Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation

  NCT04788888· Abbott Medical Devices· Source

• Active, not recruiting

  Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS

  NCT05027984· Centro per la Lotta Contro l'Infarto - Fondazione Onlus· Source

• Recruiting

  Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure

  NCT06884631· Centro Cardiologico Monzino· Source

• Active, not recruiting

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

• Recruiting

  Resorbable Magnesium Scaffolds Registry

  NCT04679740· Biotronik AG· Source

• Recruiting

  The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients

  NCT04405583· Occlutech International AB· Source

• Recruiting

  Abbott Vascular Medical Device Registry

  NCT04573660· Abbott Medical Devices· Source

• Active, not recruiting

  Impact of Stress CT Myocardial Perfusion on Downstream Resources and Prognosis

  NCT03976921· Centro Cardiologico Monzino· Source

• Active, not recruiting

  Inspiris Resilia Durability Registry

  NCT03666741· Institut für Pharmakologie und Präventive Medizin· Source

• Active, not recruiting

  AMPLATZER PFO Occluder Post Approval Study

  NCT03309332· Abbott Medical Devices· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease9 recruiting
• Heart failure8 recruiting
• Aortic stenosis4 recruiting
• Atrial fibrillation3 recruiting
• Amyloidosis2 recruiting
• Dilated cardiomyopathy2 recruiting
• Myocarditis2 recruiting
• Fabry disease1 recruiting
• Obesity1 recruiting
• Stroke1 recruiting

Closed trials

• Completed

  FOCALFLEX (CE Mark) Study

  NCT06271967· Abbott Medical Devices· Source

• Completed

  EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs

  NCT06316128· Heart Care Foundation· Source

• Completed

  A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter

  NCT05970120· Biosense Webster, Inc.· Source

• Completed

  AnGiographic Performance With A Sirolimus-elutiNG Balloon in the TrEatment of De Novo CoronaRy Artery Disease

  NCT05471245· Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS· Source

• Completed

  Artificial Intelligence Models to Predict Clinically Relevant Cardiovascular Outcomes

  NCT06847100· Centro Cardiologico Monzino· Source

• Completed

  Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast Cancer

  NCT05775822· Centro Cardiologico Monzino· Source

• Completed

  Effect of the Use of Protective Masks on the Ability to Perform Daily Activities in Patients with Heart Failure or Obstructive Pulmonary Disease

  NCT05762406· Centro Cardiologico Monzino· Source

• Completed

  Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia

  NCT04864795· Vifor (International) Inc.· Source

• Completed

  A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag

  NCT04567602· Janssen-Cilag S.p.A.· Source

• Terminated

  The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO

  NCT04029233· Occlutech International AB· Source

• Completed

  A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

  NCT03914326· Phase 3· Novo Nordisk A/S· Source

• Completed

  Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation

  NCT03795298· Boston Scientific Corporation· Source

• Completed

  Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study

  NCT03666780· Lifetech Scientific (Shenzhen) Co., Ltd.· Source

• Completed

  DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation

  NCT03643224· Medtronic Cardiac Ablation Solutions· Source

• Completed

  FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study

  NCT03490201· Abbott Medical Devices· Source

• Completed

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· Phase 3· CSL Behring· Source

• Completed

  Surfactant Derived Protocol in Heart Failure

  NCT06896461· Centro Cardiologico Monzino· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Heart failure103 works · 13 trials
• Atrial fibrillation60 works · 13 trials
• Coronary artery disease51 works · 21 trials
• Aortic stenosis21 works · 7 trials
• Hypertrophic cardiomyopathy16 works · 1 trial
• Ventricular tachycardia16 works · 2 trials
• Dilated cardiomyopathy7 works · 2 trials